SmithKline could hand back pounds 5bn
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.SMITHKLINE BEECHAM yesterday raised the prospect of a huge return of cash to investors with plans to seek shareholder approval to buy back almost pounds 5bn worth of shares. The drug giant said that it would ask its next shareholders' meeting at the end of April for permission to purchase up to 10 per cent of its own stock.
The company said that it had no immediate plans for its first-ever share buyback. However, it added that the move would give it "greater flexibility" in spending surplus cash, which is set to be boosted by asset sales and growing drug sales. During 1999, SB will receive around $2bn in cash and shares from the sale of two US businesses.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments